Australia markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
179.74+3.47 (+1.97%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close176.27
Open174.60
Bid181.00 x 1100
Ask180.13 x 800
Day's range174.02 - 184.41
52-week range16.41 - 331.68
Volume2,142,191
Avg. volume4,289,490
Market cap13.275B
Beta (5Y monthly)1.47
PE ratio (TTM)N/A
EPS (TTM)-7.27
Earnings date01 Mar 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est300.75
  • Editor's pick
    Yahoo Finance Video

    Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’: Doctor

    Dr. Shereef Elnahal, University Hospital CEO, Former NJDOH Commissioner, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on coronavirus vaccines.

  • 3 Stocks That Could Suffer if Biden Gives In to This Pressure
    Motley Fool

    3 Stocks That Could Suffer if Biden Gives In to This Pressure

    A proposal currently before the World Trade Organization would waive patent rights on COVID-19 vaccines and treatments in an effort to help low-income nations. Several top Democrats appear to support the move, although the Biden administration has yet to state a position publicly. Despite the push, the president may be hesitant to override patents for pharmaceuticals.

  • 3 Biotech Stocks With Big Catalysts Around the Corner
    Motley Fool

    3 Biotech Stocks With Big Catalysts Around the Corner

    Investors hungry for stocks that could make big movements in short time spans know that the biotech industry is full of them. This company is the first to submit an application to the Food and Drug Administration for a new drug designed to slow the progress of Alzheimer's disease.